Screening of 31 genes involved in monogenic forms of obesity in 23 Pakistani probands with early-onset childhood obesity: a case report.


Journal

BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552

Informations de publication

Date de publication:
05 09 2019
Historique:
received: 18 03 2019
accepted: 29 08 2019
entrez: 7 9 2019
pubmed: 7 9 2019
medline: 4 12 2019
Statut: epublish

Résumé

Consanguine families display a high degree of homozygosity which increases the risk of family members suffering from autosomal recessive disorders. Thus, homozygous mutations in monogenic obesity genes may be a more frequent cause of childhood obesity in a consanguineous population. We identified 23 probands from 23 Pakistani families displaying autosomal recessive obesity. We have previously excluded mutations in MC4R, LEP and LEPR in all probands. Using a chip-based, target-region capture array, 31 genes involved in monogenic forms of obesity, were screened in all probands. We identified 31 rare non-synonymous possibly pathogenic variants (28 missense and three nonsense) within the 31 selected genes. All variants were heterozygous, thus no homozygous pathogenic variants were found. Two of the rare heterozygous nonsense variants identified (p.R75X and p.R481X) were found in BBS9 within one proband, suggesting that obesity is caused by compound heterozygosity. Sequencing of the parents supported the compound heterozygous nature of obesity as each parent was carrying one of the variants. Subsequent clinical investigation strongly indicated that the proband had Bardet-Biedl syndrome. Mutation screening in 31 genes among probands with severe early-onset obesity from Pakistani families did not reveal the presence of homozygous obesity causing variants. However, a compound heterozygote carrier of BBS9 mutations was identified, indicating that compound heterozygosity must not be overlooked when investigating the genetic etiology of severe childhood obesity in populations with a high degree of consanguinity.

Sections du résumé

BACKGROUND
Consanguine families display a high degree of homozygosity which increases the risk of family members suffering from autosomal recessive disorders. Thus, homozygous mutations in monogenic obesity genes may be a more frequent cause of childhood obesity in a consanguineous population.
METHODS
We identified 23 probands from 23 Pakistani families displaying autosomal recessive obesity. We have previously excluded mutations in MC4R, LEP and LEPR in all probands. Using a chip-based, target-region capture array, 31 genes involved in monogenic forms of obesity, were screened in all probands.
RESULTS
We identified 31 rare non-synonymous possibly pathogenic variants (28 missense and three nonsense) within the 31 selected genes. All variants were heterozygous, thus no homozygous pathogenic variants were found. Two of the rare heterozygous nonsense variants identified (p.R75X and p.R481X) were found in BBS9 within one proband, suggesting that obesity is caused by compound heterozygosity. Sequencing of the parents supported the compound heterozygous nature of obesity as each parent was carrying one of the variants. Subsequent clinical investigation strongly indicated that the proband had Bardet-Biedl syndrome.
CONCLUSIONS
Mutation screening in 31 genes among probands with severe early-onset obesity from Pakistani families did not reveal the presence of homozygous obesity causing variants. However, a compound heterozygote carrier of BBS9 mutations was identified, indicating that compound heterozygosity must not be overlooked when investigating the genetic etiology of severe childhood obesity in populations with a high degree of consanguinity.

Identifiants

pubmed: 31488071
doi: 10.1186/s12881-019-0886-8
pii: 10.1186/s12881-019-0886-8
pmc: PMC6727494
doi:

Substances chimiques

Codon, Nonsense 0
LEP protein, human 0
LEPR protein, human 0
Leptin 0
MC4R protein, human 0
Receptor, Melanocortin, Type 4 0
Receptors, Leptin 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152

Références

Endocrine. 2014 Apr;45(3):401-8
pubmed: 23824601
J Pak Med Assoc. 1997 Mar;47(3):75-8
pubmed: 9131857
Handb Clin Neurol. 2014;124:93-106
pubmed: 25248581
Congenit Anom (Kyoto). 2018 Sep;58(5):173-175
pubmed: 29232001
Clin Genet. 2001 Aug;60(2):89-98
pubmed: 11553039
BMC Med Genet. 2016 Feb 04;17:10
pubmed: 26846096
J Med Genet. 2002 Aug;39(8):594-6
pubmed: 12161602
Nat Methods. 2010 Aug;7(8):575-6
pubmed: 20676075
Nat Rev Genet. 2009 Jul;10(7):431-42
pubmed: 19506576
J Nutr. 2007 Jan;137(1):153-7
pubmed: 17182818
Nat Rev Genet. 2005 Mar;6(3):221-34
pubmed: 15703762
Am J Hum Genet. 2006 May;78(5):889-896
pubmed: 16642444
PLoS One. 2012;7(3):e34389
pubmed: 22479622
Hum Mutat. 2015 Jul;36(7):660-8
pubmed: 25846608
Obes Facts. 2016;9(3):158-73
pubmed: 27241181
Stat Med. 1992 Jul;11(10):1305-19
pubmed: 1518992
BMC Med Genet. 2018 Nov 15;19(1):199
pubmed: 30442103
Behav Genet. 1997 Jul;27(4):325-51
pubmed: 9519560
Mol Vis. 2017 Jul 21;23:482-494
pubmed: 28761321
Science. 2006 Aug 4;313(5787):629-33
pubmed: 16888132
Int J Pediatr Obes. 2011 Oct;6(5-6):419-27
pubmed: 21854111
BMC Genet. 2014 Jan 29;15:13
pubmed: 24476040
Cell. 2007 Jun 15;129(6):1201-13
pubmed: 17574030
JAMA. 1986 Jul 4;256(1):51-4
pubmed: 3712713
Vitam Horm. 2013;91:29-48
pubmed: 23374711
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nat Genet. 2006 Jun;38(6):623-5
pubmed: 16682970
Nat Genet. 2018 Feb;50(2):172-174
pubmed: 29311636
Hum Mutat. 2010 Oct;31(10):1097-108
pubmed: 20690115
J Nutr. 2004 Feb;134(2):295-8
pubmed: 14747663
Am J Clin Nutr. 2009 Mar;89(3):980S-984S
pubmed: 19211814
Cell. 1990 Feb 9;60(3):495-508
pubmed: 2154334
Diabetologia. 2015 May;58(5):1006-12
pubmed: 25660259
Am J Hum Genet. 1996 Aug;59(2):279-86
pubmed: 8755945
Diabetes. 2012 Feb;61(2):383-90
pubmed: 22210313
Nat Genet. 2018 Feb;50(2):175-179
pubmed: 29311637
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nature. 1997 Jun 26;387(6636):903-8
pubmed: 9202122
Endocrinology. 2003 Sep;144(9):3757-64
pubmed: 12933645
Endocr Rev. 2016 Aug;37(4):347-71
pubmed: 27187081
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
C R Biol. 2017 Feb;340(2):87-108
pubmed: 28089486
Diabetes. 2008 Sep;57(9):2511-8
pubmed: 18559663
Soc Biol. 2000 Fall-Winter;47(3-4):189-200
pubmed: 12055694
Obesity (Silver Spring). 2015 Aug;23(8):1687-95
pubmed: 26179253
J Am Coll Surg. 2008 Dec;207(6):928-34
pubmed: 19183541
N Engl J Med. 2007 Jan 18;356(3):237-47
pubmed: 17229951
Nature. 1998 Mar 26;392(6674):398-401
pubmed: 9537324
J Public Health Med. 1994 Dec;16(4):423-8
pubmed: 7880573
Nat Genet. 1998 Oct;20(2):111-2
pubmed: 9771698
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
Obesity (Silver Spring). 2014 Apr;22(4):1112-7
pubmed: 24319006
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590

Auteurs

Robina Khan Niazi (RK)

Department of Biological Sciences, International Islamic University, Islamabad, Pakistan.
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Children Hospital, Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.

Anette Prior Gjesing (AP)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. anette.gjesing@sund.ku.dk.

Mette Hollensted (M)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Christian Theil Have (CT)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Dmitrii Borisevich (D)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Niels Grarup (N)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Oluf Pedersen (O)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Asmat Ullah (A)

Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Department of Molecular Biology, Shaheed Zulfiqar Ali Bhutto Medical University, PIMS, Islamabad, Pakistan.

Gulbin Shahid (G)

Children Hospital, Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.

Ifrah Shafqat (I)

Department of Biological Sciences, International Islamic University, Islamabad, Pakistan.

Asma Gul (A)

Department of Biological Sciences, International Islamic University, Islamabad, Pakistan.

Torben Hansen (T)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH